Aquaporin-1 sustains lymphangiogenic responses in hyperosmotic inflammatory microenvironments.

Saved in:
Bibliographic Details
Title: Aquaporin-1 sustains lymphangiogenic responses in hyperosmotic inflammatory microenvironments.
Authors: Roci I; Department of Fundamental Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Epalinges, Switzerland., Kim J; Department of Fundamental Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Epalinges, Switzerland., de Korodi K; Department of Fundamental Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Epalinges, Switzerland., Wyss T; Department of Fundamental Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Epalinges, Switzerland., Bernier-Latmani J; Department of Fundamental Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Epalinges, Switzerland., Arroz-Madeira S; Department of Fundamental Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Epalinges, Switzerland., González-Loyola A; Department of Fundamental Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Epalinges, Switzerland., Bovay E; Department of Fundamental Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Epalinges, Switzerland., Grenningloh N; Department of Fundamental Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Epalinges, Switzerland., Schoofs H; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Jeon NL; Department of Mechanical Engineering, Seoul National University, Seoul, Republic of Korea.; Institute of Advanced Machinery and Design, Seoul National University, Seoul, Republic of Korea., Giampietro C; Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.; Swiss Federal Laboratories for Materials Science and Technology , Dübendorf, Switzerland., Mäkinen T; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Wihuri Research Institute, Biomedicum Helsinki, Helsinki, Finland.; Faculty of Medicine, University of Helsinki, Helsinki, Finland., Noël A; Laboratory of Tumor and Development Biology, GIGA, University of Liège, Liège, Belgium.; WELBIO Department, WEL Research Institute, Wavre, Belgium., Petrova TV; Department of Fundamental Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Epalinges, Switzerland.; Swiss Institute for Experimental Cancer Research, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Source: The Journal of experimental medicine [J Exp Med] 2026 Jul 06; Vol. 223 (7). Date of Electronic Publication: 2026 Jun 01.
Publication Type: Journal Article
Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-9538
DOI:10.1084/jem.20250506